Monrovia - The Partnership for Research on Ebola Virus in Liberia (PREVAIL) has received high marks for its ongoing research program in Liberia. PREVAIL is the Partnership for Research on Ebola Virus in Liberia. October 2017 was a significant milestone for the vaccine study and as more and more people were reached through community engagements. Lassana Gebah and other residents said it is important for Liberians to enroll in this follow-up Vaccine Study. The ongoing Ebola Vaccine Study, otherwise known as PREVAIL 5, is taking place at the Redemption Hospital in New Kru Town, the venue of the first vaccine study conducted in 2015.

Source: Front Page Africa November 08, 2017 02:48 UTC